CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. clinical trials
Acquired by CSPC Pharmaceutical Group Limited
The registry lists 26 studies whose lead sponsor is CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 30, 2026.
Where
- China
- 17
Registry sponsor names on this page
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.26 studies
Something wrong with this grouping? Tell us on the CSPC Pharmaceutical Group Limited page.
Studies
Recruiting first, then most recently updated. Showing 26 of 26. All CSPC Pharmaceutical Group Limited studies →
- A Comparative Pharmacokinetic Study of CM326 in Healthy SubjectsNot yet recruitingNCT07560033Phase 1
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- A Phase III Study of CM326 in Subjects With Moderate to Severe AsthmaRecruitingNCT07372287Phase 3
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and ObesityRecruitingNCT06830343Phase 1
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal PolyposisNot yet recruitingNCT07420257Phase 3
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- Semaglutide in Treatment of ObesityCompletedNCT06604624Phase 3
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes MellitusCompletedNCT06235086Phase 3
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes MellitusCompletedNCT06258148Phase 3
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- A Study of TG103 Injection in Non-diabetic Overweight or ObesityCompletedNCT05997576Phase 3
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- A Study of TG103 Injection in the Management of Non-diabetic Overweight or ObesityCompletedNCT06226090Phase 2
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- A Study of TG103 Injection in Overweight/Obese Subjects Without DiabetesCompletedNCT04855292Phase 1
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- A Study of TG103 Injection in Type 2 Diabetes SubjectsStatus unknownNCT05348122Phase 2
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- A Study of TG103 Injection in Overweight or ObesityStatus unknownNCT05299697Phase 2
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male SubjectsCompletedNCT04839744Phase 1
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 DiabetesStatus unknownNCT05063253Phase 2
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- Study to Evaluate the Therapeutic Equivalence of SYN008 Versus Xolair® in the Treatment of Patients With Refractory Chronic Spontaneous UrticariaStatus unknownNCT04944602Phase 3
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic SyndromeStatus unknownNCT04500886Not applicable
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological MalignanciesStatus unknownNCT04497701Not applicable
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's LymphomaStatus unknownNCT04497688Not applicable
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic CancerStatus unknownNCT04239001Not applicable
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- Evaluation of the Application of PEGylated Recombinant Human Granulocyte Stimulating Factor Injection (PEG-rhG-CSF) in Chemotherapy of Elderly Lymphoma PatientsStatus unknownNCT03870412Not applicable
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced NeutropeniaStatus unknownNCT03846414
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving ChemotherapyStatus unknownNCT03776604Not applicable
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- PEG-rhG-CSF in Patients With Lymphoma Receiving ChemotherapyCompletedNCT02805218Phase 4
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- PEG-rhG-CSF in Patients With Breast Cancer Receiving ChemotherapyCompletedNCT02805153Phase 4
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent NeutropeniaCompletedNCT02805205Phase 4
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group
- PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving ChemotherapyCompletedNCT02805166Phase 4
Sponsor listed in the registry: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — acquired company within the CSPC Pharmaceutical Group Limited group